Clinical Trials Browser

Adenocarcinoma Of Esophagus × Cetuximab × 1 year × Clear all

NCT05745857 2026-04-13

SLURP

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT05104567 2025-09-24

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Phase 2 Completed

138 enrolled 32 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms